Jason Gardner

Insider Reports History

Entity
Individual
Location
C/O Magenta Therapeutics, 50 Hampshire Street, Cambridge, MA
Signature
/s/ Cindy Driscoll, Attorney-in-Fact for Jason Gardner
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jason Gardner:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Magenta Therapeutics, Inc. Title: President and Chief Executive Officer, Director Common Stock 359K $4.31M $12.00 Nov 30, 2022 By P.S. Gardner Irrevocable Trust
Magenta Therapeutics, Inc. Title: President and Chief Executive Officer, Director Common Stock 293K $3.52M $12.00 Nov 30, 2022 By J.P. Gardner Irrevocable Trust
Magenta Therapeutics, Inc. Title: President and Chief Executive Officer, Director Common Stock 293K $3.51M $12.00 Nov 30, 2022 Direct

Insider Reports Filed by Jason Gardner

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MGTA Magenta Therapeutics, Inc. Nov 30, 2022 1 $2.82K 4 Dec 2, 2022 Title: President and Chief Executive Officer, Director
MGTA Magenta Therapeutics, Inc. Aug 1, 2022 1 $0 4 Aug 1, 2022 Title: President and Chief Executive Officer Exhibit 24.1: Power of Attorney, Director
MGTA Magenta Therapeutics, Inc. May 31, 2022 1 $2.97K 4 Jun 6, 2022 Title: President and Chief Executive Officer, Director
MGTA Magenta Therapeutics, Inc. May 17, 2022 1 $0 4 May 19, 2022 Title: President and Chief Executive Officer, Director
MGTA Magenta Therapeutics, Inc. Feb 15, 2022 1 $0 4 Feb 17, 2022 Title: President and Chief Executive Officer, Director
MGTA Magenta Therapeutics, Inc. Sep 16, 2021 1 -$96.5K 4 Sep 20, 2021 President and Chief Executive Officer
MGTA Magenta Therapeutics, Inc. Sep 14, 2021 1 $0 4 Sep 16, 2021 President and Chief Executive Officer, Director
MGTA Magenta Therapeutics, Inc. Aug 2, 2021 1 $0 4 Aug 3, 2021 Title: President and Chief Executive Officer, Director